SSU72L1
RNA polymerase II subunit A C-terminal domain phosphatase SSU72 like protein 1
Also known as: S72L1_HUMAN
Protein identityUniProt · HPA
- UniProt accession
- A0A1W2PQ27
- Gene
- SSU72L1
- Canonical length
- 194 aa
OverviewNCBI Gene
No narrative summary is available for SSU72L1 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
194 residues, UniProt reviewed canonical sequence.
>A0A1W2PQ27|SSU72L1
1 MLSSTLRVAV VCVSNVNRSM EAHSILRRKG LSVRSFGTES HVRLPGPRPN RPVVYDFATT
61 YKEMYNDLLR KDRERYTRNG ILHILGRNER IKPGPERFQE CTDFFDVIFT CEESVYDTVV
121 EDLCSREQQT FQPVHVINME IQDTLEDATL GAFLICEICQ CLQQSDDMED NLEELLLQME
181 EKAGKSFLHT VCFYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SSU72L1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.27
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SSU72L1 as an antibody target. Whether an autoantibody or antibody against SSU72L1 could matter depends on whether native SSU72L1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SSU72L1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SSU72L1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...